DUBLIN–(BUSINESS WIRE)–The “Europe Artificial Tears Market Research and Forecast 2022-2028” report has been added to ResearchAndMarkets.com’s offering.
The European artificial tear market is growing at a significant CAGR of 4.6%
The market is growing due to various factors such as the increasing prevalence of dry eye syndrome. Artificial tears are used to lubricate dry eyes and moisturize the outer surface of the eyes. It is also used to treat dry eyes caused due to surgery, certain medical conditions, medications aging, and smoky or windy conditions, among others.
The incidence and prevalence of dry eye are rising among the population, especially in developed nations of Europe. Dry eye is caused by multiple factors that result in discomfort, irritation, and visual disturbance. For instance, in April 2020, according to a study ‘National Health and Wellness Survey’ conducted in Germany, ~7.4 million people were diagnosed with dry eye.
The data also stated that the prevalence has gone up by 2.7% among people of age 18?34 years. Additionally, the prevalence was 18.6% among older people. Based on sex, the percentage of prevalence was higher in women; it accounted for 8.8% than men with 4.5%.
However, various factors are restraining the market growth including side effects caused by artificial tears resulting in eye pain, red eyes, irritation, among others. Although, innovations such as preservative-free artificial tears in artificial tears could be perceived as a major opportunity for the players engaged in the market.
The European artificial tears market is segmented based on type, application, and delivery method. Based on type, the market is segmented into cellulose-derived tears, glycerin-derived tears, oil-based emulsion tears, polyethylene glycol- & propylene glycol-based tears. Based on application, the market is fragmented into dry type treatment, contact lens moisture, others. Based on the delivery method, the market is bifurcated into eye drops and, ointments.
Geographically, the market is classified into the UK, Germany, France, Spain, Italy, and the Rest of Europe. While, the key companies included in the report of the European artificial tear market are Abbott Medical Optics Inc., Akorn, Inc., Alcon Laboratories, Inc., Allergan, Inc., Bausch and Lomb, Johnson & Johnson, Novartis International AG, Ocusoft Inc., Rohto Pharmaceutical Co., Ltd, Santen Pharmaceutical Co. Ltd, Similasan Corp., URSAPHARM Arzeinmittel GmbH, WUHAN Yuanda, among more.
The companies operating in the artificial tears market are constantly focusing on product launches covering a wide range of users, R&Ds, partnerships, M&As, and technological advancements.
The report also includes a detailed market overview, strategic recommendations, key company analysis, key findings, analyst insights, predictive analysis, pipeline analysis, market determinants, market segmentation, geographical analysis, and company profiling of the market.
The Report Covers
- Comprehensive research methodology of the European artificial tears market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the European artificial tears market.
- Insights about market determinants that are stimulating the European artificial tears market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players
Key Topics Covered:
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. COVID-19 Impact on Market
2.3. Analyst Insight & Current Market Trends
2.3.1. Key Findings
2.3.2. Recommendations
2.3.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Key Strategy Analysis
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. European Artificial Tears Market by Type
5.1.1. Cellulose-Derived Tears
5.1.2. Glycerin-Derived Tears
5.1.3. Oil-Based Emulsion Tears
5.1.4. Polyethylene Glycol- & Propylene Glycol-Based Tears
5.2. European Artificial Tears Market by Application
5.2.1. Dry Type Treatment
5.2.2. Contact Lens Moisture
5.3. European Artificial Tears Market Delivery Method
5.3.1. Eyedrops
5.3.2. Ointments
6. Regional Analysis
6.1. Europe
6.1.1. UK
6.1.2. Germany
6.1.3. Italy
6.1.4. Spain
6.1.5. France
6.1.6. Rest of Europe
7. Company Profiles
7.1. Abbott Medical Optics, Inc.
7.2. Akorn, Inc.
7.3. Alcon, Inc.
7.4. Allergan, PLC
7.5. Bausch And Lomb, Inc.
7.6. Carl Zeiss Meditec AG
7.7. Johnson And Johnson Service, Inc.
7.8. Nicox S.A.
7.9. Novagali Pharma S.A.
7.10. Novamedica LLC
7.11. Novartis International AG
7.12. Novaliq GMBH
7.13. Ocusoft Inc.
7.14. Shire PLC
7.15. Similasan Corp.
7.16. Sylentis S.A.
7.17. Ursapharm Arzneimittel GmbH
7.18. Ziemer Ophthalmic System AG
For more information about this report visit https://www.researchandmarkets.com/r/3sjw3x
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900